Guglielmo A, Reader A, Nist R, Beck M, Weaver J
The Ohio State University, Columbus 43210, USA.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Mar;87(3):284-93. doi: 10.1016/s1079-2104(99)70210-6.
The purpose of this study was to determine the anesthetic efficacy and heart rate effects of a supplemental intraosseous injection of 2% mepivacaine with 1:20,000 levonordefrin.
Through use of a repeated-measures design, 40 subjects randomly received 3 combinations of injections at 3 separate appointments. The combinations were as follows: inferior alveolar nerve (IAN) block (with 3% mepivacaine) + intraosseous injection of 1.8 mL of 2% mepivacaine with 1:20,000 levonordefrin; IAN block + intraosseous injection of 1.8 mL of 2% lidocaine with 1:100,000 epinephrine (positive control); IAN block + mock intraosseous injection (negative control). Each first molar, second molar, and second premolar was blindly tested with a pulp tester at 2-minute cycles for 60 minutes after injection. Anesthesia was considered successful when 2 consecutive readings of 80 were obtained. Heart rate (pulse rate) was measured with a pulse oximeter.
One hundred percent of the subjects had lip numbness with the IAN block + intraosseous mock technique and IAN block + intraosseous techniques. The anesthetic success rates for IAN block + mock intraosseous injection, IAN block + intraosseous lidocaine, and IAN block + intraosseous mepivacaine, respectively, were as follows: 80%, 100%, and 100% for the first molar; 90%, 100%, and 100% for the second molar; 77%, 97%, and 97% for the second premolar. For the first molar and second premolar, the differences were significant (P< .05) when the intraosseous mepivacaine and lidocaine techniques were compared with the IAN block + mock intraosseous injection. There were no significant differences between the intraosseous mepivacaine and lidocaine techniques. Eighty percent of the subjects had a mean increase in heart rate of 23-24 beats per minute with the intraosseous injection of the mepivacaine and lidocaine solutions; there were no significant differences between results with the 2 solutions.
We concluded that intraosseous injection of 1.8 mL of 2% lidocaine with 1:100,000 epinephrine or 2% mepivacaine with 1:20,000 levonordefrin, used to supplement an IAN block, significantly increased anesthetic success in first molars and second premolars. The 2 solutions were equivalent with regard to intraosseous anesthetic success rate, failure rate, and heart rate increase after IAN block.
本研究的目的是确定补充骨内注射2%甲哌卡因与1:20,000左去氧肾上腺素的麻醉效果和心率影响。
采用重复测量设计,40名受试者在3次单独的预约中随机接受3种注射组合。组合如下:下牙槽神经(IAN)阻滞(用3%甲哌卡因)+骨内注射1.8 mL 2%甲哌卡因与1:20,000左去氧肾上腺素;IAN阻滞+骨内注射1.8 mL 2%利多卡因与1:100,000肾上腺素(阳性对照);IAN阻滞+模拟骨内注射(阴性对照)。每次注射后,在2分钟的周期内,用牙髓测试仪对每颗第一磨牙、第二磨牙和第二前磨牙进行60分钟的盲法测试。当连续两次读数达到80时,麻醉被认为成功。用脉搏血氧仪测量心率(脉搏率)。
100%的受试者在IAN阻滞+模拟骨内注射技术和IAN阻滞+骨内注射技术下出现唇部麻木。IAN阻滞+模拟骨内注射、IAN阻滞+骨内注射利多卡因和IAN阻滞+骨内注射甲哌卡因的麻醉成功率分别如下:第一磨牙为80%、100%和100%;第二磨牙为90%、100%和100%;第二前磨牙为77%、97%和97%。对于第一磨牙和第二前磨牙,将骨内注射甲哌卡因和利多卡因技术与IAN阻滞+模拟骨内注射进行比较时,差异有统计学意义(P<0.05)。骨内注射甲哌卡因和利多卡因技术之间无显著差异。80%的受试者在骨内注射甲哌卡因和利多卡因溶液后,心率平均每分钟增加23 - 24次;两种溶液的结果之间无显著差异。
我们得出结论,骨内注射1:100,000肾上腺素的1.8 mL 2%利多卡因或1:20,000左去氧肾上腺素的2%甲哌卡因用于补充IAN阻滞,可显著提高第一磨牙和第二前磨牙的麻醉成功率。两种溶液在IAN阻滞后的骨内麻醉成功率、失败率和心率增加方面相当。